Abstract: Novel trifluoromethanesulfonanilide oxime ether compounds useful for controlling endo and/or ectoparasites in the environment are provided, together with methods of making the same, and methods of using the inventive compounds to treat parasite infestations in vivo or ex vivo.
Type:
Grant
Filed:
September 21, 2005
Date of Patent:
December 25, 2007
Assignee:
Schering-Plough Animal Health Corporation
Inventors:
Adam Gerhard Meyer, Kevin Norman Winzenberg, David G. Sawutz, Andris Juris Liepa